Eisai Inc

Pyxis Oncology, Inc., located in Boston, is dedicated to developing therapeutics for difficult-to-treat cancers. The company is focused on charting a course towards innovative solutions to address the challenges of these complex diseases. Generated from their website's infomation

Syntonix Pharmaceuticals is engaged in the discovery and development of novel, long-acting, proprietary therapeutic products that utilize the company s proprietary Fc-fusion proteins and other engineered ligands that bind to specific Fc receptors. These technologies, including the Transceptor drug-delivery platform, are designed to use the body s natural protection of antibodies against premature destruction and for the transport of antibodies across cell barriers. The company focuses on using these technologies to create next-generation treatments for chronic diseases such as hemophilia, anemia and autoimmune disorders. It develops selected products for specialty indications and evaluates and commercializes other products through partnerships. The company occupies a 25,000-square-foot laboratory facility that includes a clinical manufacturing suite. Syntonix Pharmaceuticals is headquartered in Waltham, Mass.

Amgen is a global leader in biotechnology, dedicated to the development of innovative biologic medicines that address serious illnesses, particularly in areas with limited treatment options. The company's mission encompasses a commitment to scientific advancement, patient safety, and corporate responsibility, reflecting its core values of integrity and excellence. With a strong focus on research and development, Amgen employs cutting-edge technologies, including AI and data science, to optimize clinical trials and enhance drug design. The company also prioritizes community investment, diversity, and sustainability, striving to make a positive impact on healthcare access and health equity worldwide. Generated from the website